[1] STEG PG,JAMES SK,ATAR D,et al.ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J].Eur Heart J,2012,33(20):2569.
[2] STONE GW,WITZENBICHLER B,GUAGLIUMI G,et al.Heparin plus a glycoprotein Ⅱb/Ⅲa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI):final 3-year results from a multicentre,randomised controlled trial[J].Lancet,2011,377(9784):2193.
[3] 武洪杰.重组型纤溶酶原激活剂与尿激酶在急性心肌梗死溶栓治疗中的比较[J].安徽医学,2011,32(1):59.
[4] 宋德明,孙爱娇,乔锐,等.急诊经皮冠状动脉介入治疗急性心肌梗死的临床疗效评估[J].安徽医学,2010,31(10):1166.
[5] IQBAL FM,HAGE FG,AHMED A,et al.Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching[J].JACC Cardiovasc Imaging,2012,5(10):1014.
[6] ZOGHBI GJ,ISKANDRIAN AE.Selective adenosine agonists and myocardial perfusion imaging[J].J Nucl Cardiol,2012,19(1):126.
[7] 高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710.
[8] SMITH SC Jr,DOVE JT,JACOBS AK,et al.ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)——executive summary.A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty)[J].J Am Coll Cardiol,2001,37(8):2239.
[9] ASSALI AR,SDRINGOLA S,GHANI M,et al.Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon[J].Catheter Cardiovasc Interv,2000,51(1):27.
[10] MAYR A,MAIR J,KLΜG G,et al.Cardiac troponin T and creatine kinase predict mid-term infarct size and left ventricular function after acute myocardial infarction:a cardiac MR study[J].J Magn Reson Imaging,2011,33(4):847.
[11] KRUSE JM,ENGHARD P,SCHRÖDER T,et al.Weak diagnostic performance of troponin,creatine kinase and creatine kinase-MB to diagnose or exclude myocardial infarction after successful resuscitation[J].Int J Cardiol,2014,173(2):216.
[12] REICHLIN T,IRFAN A,TWERENBOLD R,et al.Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction[J].Circulation,2011,124(2):136.
[13] 周浩,黄伟剑,吴高俊,等.冠脉内注射替罗非班对急性心肌梗死急诊介入治疗ST段回落的影响[J].心脑血管病防治,2011,11(1):4.
[14] 陈解忠,丁志坚,王新,等.急性ST段抬高型心肌梗死介入治疗围术期联合盐酸替罗非班和腺苷疗效观察[J].实用临床医药杂志,2012,16(11):117.
[15] NAVARESE EP,BUFFON A,ANDREOTTI F,et al.Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome:a meta-analysis of randomized trials[J].Atherosclerosis,2012,222(1):1.
[16] 王晓楠.腺苷对急性心肌梗死心肌再灌注损伤的影响[D].长春:吉林大学,2005.
[17] 韩建妙,籍振国,周素华,等.腺苷对急性心肌梗死经皮冠状动脉介入治疗患者的心肌保护作用[J].临床荟萃,2006,21(20):1459.